DiLumen Endolumenal Therapy System for Procedures Inside Large Intestine FDA Cleared
December 23rd, 2016
Lumendi, LLC, a U.S. subsidiary of Lumendi, Ltd. out of London, England, won FDA clearance for its DiLumen endolumenal therapy system. The system is designed to isolate a section of the large intestine, to position the endoscope within it for a good viewing angle, and to help with delivery of incision-free endolumenal therapies.
The DiLumen was an idea that came out of the Minimally Invasive New Technologies program (MINT) at Weill Cornell Medicine and New York-Presbyterian, and developed by MINT and Lumendi.